- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06729775
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal of this intervention study is to learn if the data report back design type can modify data and environmental health literacy learning outcomes in adolescence (10~19 yrs.), young adults (18-26 yrs.) (110), and adults (27 yrs.+).
The main questions it aims to answer are:
- How does design type: (1) graphical (control), art-infused (treatment 1) and geospatial (treatment 2) influence data and environmental health literacy learning outcomes related to numeracy and data literacy?
- How does design type: (1) graphical (control), art-infused (treatment 1) and geospatial (treatment 2) influence data and environmental health literacy learning outcomes related to knowledge and awareness related to environmental risks?
- How does design type: (1) graphical (control), art-infused (treatment 1) and geospatial (treatment 2) influence data and environmental health literacy learning outcomes related to skills and self-efficacy for environmental action?
- How does design type: (1) graphical (control), art-infused (treatment 1) and geospatial (treatment 2) influence data and environmental health literacy learning outcomes related to engaging in environmental health activities?
- [primary hypothesis or outcome measure 1]?
- [primary hypothesis or outcome measure 2]?
Researchers will compare outcomes related to life span and design type to see if the design type leads to difference data and environmental health literacy learning outcomes by life stage. During analysis, in addition to life stage, participants will also be analyzed by select sociodemographic variables, e.g., income, education, and race/ethnicity.
Participants will be asked to:
- Complete a pre-survey (baseline)
- Complete a post-survey
- Review their randomly assigned repot back design
- Participate in a focus group and answer questions about the design
- At minimum of six months later, participate in an interview
Summary statistics and qualitative summaries of findings will be generated and used to inform interpretation of inferential statistical tests comparing subgroups. Statistical analyses (i.e., Chi square tests, plus Cramér's V, Multivariate analysis of variance (MANOVA), Kruskal-Wallis, and/or Mann-Whitney U tests) will be conducted to determine any significant differences related to (1) numeracy and data literacy, (2) knowledge and awareness related to environmental risks and (3) skills and self-efficacy for environmental action occur by data report back design type and sociodemographic variables.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Monica D Ramirez-Andreotta, PhD, Environmental Science
- Phone Number: 520-621-0091
- Email: mdramire@arizona.edu
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85721
- Recruiting
- University of Arizona
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants should live in Pinal county, Arizona, Gila county, Arizona, and Cuyahoga county, Ohio.
Exclusion Criteria:
- Individuals living outside of the partnering counties will not be eligible for participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: adolescence - graphical
adolescence (10~19 yrs.) that receives a traditional graphical (figures/charts/tables) representation of environmental health/quality data
|
Data report back preference by life span.
|
|
Active Comparator: adolescence - art-infused
adolescence (10~19 yrs.) that receives an environment art representation of environmental health/quality data
|
Data report back preference by life span.
|
|
Active Comparator: adolescence - geospatial
adolescence (10~19 yrs.) that receives a geospatial representation of environmental health/quality data
|
Data report back preference by life span.
|
|
Active Comparator: young adults - graphical
young adults (18-26 yrs.) that receives a traditional graphical (figures/charts/tables) representation of environmental health/quality data
|
Data report back preference by life span.
|
|
Active Comparator: young adults - art-infused
young adults (18-26 yrs.) that receives an environment art representation of environmental health/quality data
|
Data report back preference by life span.
|
|
Active Comparator: young adults - geospatial
young adults (18-26 yrs.) that receives a a geospatial representation of environmental health/quality data
|
Data report back preference by life span.
|
|
Active Comparator: adults - graphical
adults (27 yrs.+) that receives a traditional graphical (figures/charts/tables) representation of environmental health/quality data
|
Data report back preference by life span.
|
|
Active Comparator: adults - art-infused
adults (27 yrs.+) that receives an environment art representation of environmental health/quality data
|
Data report back preference by life span.
|
|
Active Comparator: adults - geospatial
adults (27 yrs.+) that receives a geospatial representation of environmental health/quality data
|
Data report back preference by life span.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes from baseline in the mean literacy and numeracy based on questionnaire responses.
Time Frame: From enrollment to the end of treatment at 78 weeks
|
Likert scale where one is equivalent to "Disagree Very Strongly" and six is Agree Very Strongly.
|
From enrollment to the end of treatment at 78 weeks
|
|
Changes from baseline in the mean knowledge and awareness risks based on questionnaire responses.
Time Frame: From enrollment to the end of treatment at 78 weeks
|
Likert scale where one is equivalent to "Disagree Very Strongly" and six is Agree Very Strongly.
|
From enrollment to the end of treatment at 78 weeks
|
|
Changes from baseline in the mean skills and self-efficacy based on questionnaire responses.
Time Frame: From enrollment to the end of treatment at 78 weeks
|
Likert scale where one is equivalent to "Disagree Very Strongly" and six is Agree Very Strongly.
|
From enrollment to the end of treatment at 78 weeks
|
|
Changes from baseline in the mean environmental health engagement based on questionnaire responses.
Time Frame: From enrollment to the end of treatment at 78 weeks
|
Likert scale where one is equivalent to "Disagree Very Strongly" and six is Agree Very Strongly.
|
From enrollment to the end of treatment at 78 weeks
|
|
Number of participants reporting themes related to literacy and numeracy.
Time Frame: From enrollment to the end of treatment at 78 weeks
|
This is a qualitative analysis; words will be coded and analyzed to identify themes and sentiment's that arise in individual interviews and across all interviews and focus groups.
|
From enrollment to the end of treatment at 78 weeks
|
|
Number of participants reporting themes related to knowledge and awareness risks
Time Frame: From enrollment to the end of treatment at 78 weeks
|
This is a qualitative analysis; words will be coded and analyzed to identify themes and sentiment's that arise in individual interviews and across all interviews and focus groups.
|
From enrollment to the end of treatment at 78 weeks
|
|
Number of participants reporting themes related to skills and self-efficacy
Time Frame: From enrollment to the end of treatment at 78 weeks
|
This is a qualitative analysis; words will be coded and analyzed to identify themes and sentiment's that arise in individual interviews and across all interviews and focus groups.
|
From enrollment to the end of treatment at 78 weeks
|
|
Number of participants reporting themes related to environmental health engagement.
Time Frame: From enrollment to the end of treatment at 78 weeks
|
This is a qualitative analysis; words will be coded and analyzed to identify themes and sentiment's that arise in individual interviews and across all interviews and focus groups.
|
From enrollment to the end of treatment at 78 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Monica D Ramirez-Andreotta, PhD, Environmental Science, University of Arizona
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00004829
- R01ES036236 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Education, Health
-
Basque Health ServiceUnknownHealth Promotion | Health Behavior | Health Education | Patient Education | Counseling | Behavior TherapySpain
-
University Medical Center GoettingenNot yet recruitingNursing Education | Health Education | Oral Health Care | Oral Health Education
-
Liverpool John Moores UniversityUniversity of Central Lancashire; Queen's University, Belfast; Newcastle University and other collaboratorsCompletedMedical Education | Health Education | Educational AssessmentUnited Kingdom
-
Istanbul Bilgi UniversityCompleted
-
Hepatopancreatobiliary Surgery Institute of Gansu...CompletedHealth EducationChina
-
Aga Khan UniversityUnknown
-
Universidad Nacional de la MatanzaRecruiting
-
Rio de Janeiro State UniversityCompleted
-
Sheba Medical CenterWithdrawnEducation, HealthIsrael
Clinical Trials on Data report back preference by life span
-
Philipp HomanRecruitingPsychotic DisorderCzechia, Ireland, Netherlands, Norway, Switzerland, Turkey (Türkiye)
-
Campus Bio-Medico UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)CompletedOvarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Vaginal Cancer | Peritoneal Cancer | Uterine CancerUnited States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingObesity-Related Malignant NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Endometrial Carcinoma | Endometrial Endometrioid Adenocarcinoma | Triple-Negative Breast Carcinoma | Stage IV Vulvar Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IV Vaginal... and other conditionsUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaboratorsActive, not recruitingKidney Cancer | Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Colon CancerUnited States
-
Hacettepe UniversityCompletedQuality of Life | Physical Disability | Psychosocial Problem | Meniere DiseaseTurkey
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Hodgkin's Lymphoma | CNS Lymphoma | CNS Brain CancerUnited States